<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39312582</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7358</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>PLoS computational biology</Title><ISOAbbreviation>PLoS Comput Biol</ISOAbbreviation></Journal><ArticleTitle>A retrospective assessment of forecasting the peak of the SARS-CoV-2 Omicron BA.1 wave in England.</ArticleTitle><Pagination><StartPage>e1012452</StartPage><MedlinePgn>e1012452</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1012452</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pcbi.1012452</ELocationID><Abstract><AbstractText>We discuss the invasion of the Omicron BA.1 variant into England as a paradigm for real-time model fitting and projection. Here we use a mixture of simple SIR-type models, analysis of the early data and a more complex age-structure model fit to the outbreak to understand the dynamics. In particular, we highlight that early data shows that the invading Omicron variant had a substantial growth advantage over the resident Delta variant. However, early data does not allow us to reliably infer other key epidemiological parameters-such as generation time and severity-which influence the expected peak hospital numbers. With more complete epidemic data from January 2022 are we able to capture the true scale of the epidemic in terms of both infections and hospital admissions, driven by different infection characteristics of Omicron compared to Delta and a substantial shift in estimated precautionary behaviour during December. This work highlights the challenges of real time forecasting, in a rapidly changing environment with limited information on the variant's epidemiological characteristics.</AbstractText><CopyrightInformation>Copyright: © 2024 Keeling, Dyson. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keeling</LastName><ForeName>Matt J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-4639-4765</Identifier><AffiliationInfo><Affiliation>The Zeeman Institute for Systems Biology &amp; Infectious Disease Epidemiology Research, School of Life Sciences and Mathematics Institute, University of Warwick, Coventry, CV4 7AL, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint UNIversities Pandemic and Epidemiological Research, https://maths.org/juniper/.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dyson</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Zeeman Institute for Systems Biology &amp; Infectious Disease Epidemiology Research, School of Life Sciences and Mathematics Institute, University of Warwick, Coventry, CV4 7AL, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint UNIversities Pandemic and Epidemiological Research, https://maths.org/juniper/.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Comput Biol</MedlineTA><NlmUniqueID>101238922</NlmUniqueID><ISSNLinking>1553-734X</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="Y">Forecasting</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090005" MajorTopicYN="N">Epidemiological Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>22</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39312582</ArticleId><ArticleId IdType="pmc">PMC11449292</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1012452</ArticleId><ArticleId IdType="pii">PCOMPBIOL-D-24-00202</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van Kerkhove MD, Ferguson NM. Epidemic and intervention modelling: a scientific rationale for policy decisions? lessons from the 2009 influenza pandemic. Bulletin of the World Health Organization 90(4):306–310 (2012). doi: 10.2471/BLT.11.097949</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.11.097949</ArticleId><ArticleId IdType="pmc">PMC3324871</ArticleId><ArticleId IdType="pubmed">22511828</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalf CJE, Edmunds W, Lessler J. Six challenges in modelling for public health policy. Epidemics 10:93–96 (2015). doi: 10.1016/j.epidem.2014.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2014.08.008</ArticleId><ArticleId IdType="pubmed">25843392</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AN, Kraemer MU, Bhatia S, Cori A, Nouvellet P, et al.. Real-time epidemic forecasting: challenges and opportunities. Health security 17(4):268–275 (2019). doi: 10.1089/hs.2019.0022</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hs.2019.0022</ArticleId><ArticleId IdType="pmc">PMC6708259</ArticleId><ArticleId IdType="pubmed">31433279</ArticleId></ArticleIdList></Reference><Reference><Citation>Bershteyn A, Kim HY, Braithwaite RS. Real-time infectious disease modeling to inform emergency public health decision making. Annual Review of Public Health 43(1):397–418 (2022). doi: 10.1146/annurev-publhealth-052220-093319</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-052220-093319</ArticleId><ArticleId IdType="pubmed">34995131</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, et al.. Rapid epidemic expansion of the sars-cov-2 omicron variant in southern africa. Nature 603 (7902):679–686 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942855</ArticleId><ArticleId IdType="pubmed">35042229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsui JLH, McCrone JT, Lambert B, Bajaj S, Inward RP, et al.. Genomic assessment of invasion dynamics of sars-cov-2 omicron ba. 1. Science 381 (6655):336–343 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10866301</ArticleId><ArticleId IdType="pubmed">37471538</ArticleId></ArticleIdList></Reference><Reference><Citation>SAGE. SAGE 99 minutes: Coronavirus (COVID-19) response, 16 December 2021 (2021a). URL https://www.gov.uk/government/publications/sage-99-minutes-coronavirus-covid-19-response-16-december-2021/sage-99-minutes-coronavirus-covid-19-response-16-december-2021. [Online] (Accessed: 2021-12-18).</Citation></Reference><Reference><Citation>SAGE. SAGE 101 minutes: Coronavirus (COVID-19) response, 23 December 2021 (2021b). URL https://www.gov.uk/government/publications/sage-101-minutes-coronavirus-covid-19-response-23-december-2021/sage-101-minutes-coronavirus-covid-19-response-23-december-2021. [Online] (Accessed: 2021-12-24).</Citation></Reference><Reference><Citation>SAGE. SAGE 102 minutes: Coronavirus (COVID-19) response, 7 January 2022 (2022). URL https://www.gov.uk/government/publications/sage-102-minutes-coronavirus-covid-19-response-7-january-2022/sage-102-minutes-coronavirus-covid-19-response-7-january-2022. [Online] (Accessed: 2022-01-14).</Citation></Reference><Reference><Citation>SPI-M-O. SPI-M-O: Consensus Statement on COVID-19, 7 December 2021 (2021). URL https://www.gov.uk/government/publications/spi-m-o-consensus-statement-on-covid-19-7-december-2021/spi-m-o-consensus-statement-on-covid-19-7-december-2021. [Online] (Accessed: 2021-12-08).</Citation></Reference><Reference><Citation>Keeling MJ, Brooks-Pollock E, Challen R, Danon L, Dyson L, et al.. Short-term projections based on early Omicron variant dynamics in England. MedRxiv (2021a).</Citation></Reference><Reference><Citation>Barnard RC, Davies NG, Pearson CA, Jit M, Edmunds WJ. Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022. medRxiv (2021).</Citation></Reference><Reference><Citation>Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, et al.. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. The Lancet 399(10323):437–446 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8769664</ArticleId><ArticleId IdType="pubmed">35065011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson N, Ghani A, Hinsley W, Volz E. Report 50—Hospitalisation risk for Omicron cases in England (2021).</Citation></Reference><Reference><Citation>Keeling M, Dyson L. Warwick Omicron Modelling (2022). URL https://www.gov.uk/government/publications/university-of-warwick-omicron-modelling-6-january-2022. [Online] (Accessed: 2024-01-29).</Citation></Reference><Reference><Citation>Hart WS, Miller E, Andrews NJ, Waight P, Maini PK, et al.. Generation time of the alpha and delta sars-cov-2 variants: an epidemiological analysis. The Lancet Infectious Diseases 22(5):603–610 (2022a). doi: 10.1016/S1473-3099(22)00001-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00001-9</ArticleId><ArticleId IdType="pmc">PMC8843191</ArticleId><ArticleId IdType="pubmed">35176230</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart WS, Abbott S, Endo A, Hellewell J, Miller E, et al.. Inference of the sars-cov-2 generation time using uk household data. Elife 11:e70767 (2022b).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8967386</ArticleId><ArticleId IdType="pubmed">35138250</ArticleId></ArticleIdList></Reference><Reference><Citation>House T, Riley H, Pellis L, Pouwels KB, Bacon S, et al.. Inferring risks of coronavirus transmission from community household data. Statistical methods in medical research 31(9):1738–1756 (2022). doi: 10.1177/09622802211055853</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09622802211055853</ArticleId><ArticleId IdType="pmc">PMC9465559</ArticleId><ArticleId IdType="pubmed">36112916</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallinga J, Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proceedings of the Royal Society B: Biological Sciences 274 (1609):599–604 (2007). doi: 10.1098/rspb.2006.3754</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2006.3754</ArticleId><ArticleId IdType="pmc">PMC1766383</ArticleId><ArticleId IdType="pubmed">17476782</ArticleId></ArticleIdList></Reference><Reference><Citation>Kermack WO, McKendrick AG. A contribution to the mathematical theory of epidemics. Proceedings of the royal society of london. Series A, Containing papers of a mathematical and physical character 115(772):700–721 (1927).</Citation></Reference><Reference><Citation>Craft ME, Beyer HL, Haydon DT. Estimating the probability of a major outbreak from the timing of early cases: an indeterminate problem? Plos one 8(3):e57878 (2013). doi: 10.1371/journal.pone.0057878</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057878</ArticleId><ArticleId IdType="pmc">PMC3590282</ArticleId><ArticleId IdType="pubmed">23483934</ArticleId></ArticleIdList></Reference><Reference><Citation>Challen R, Brooks-Pollock E, Read JM, Dyson L, Tsaneva-Atanasova K, et al.. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ 372:n579 (2021a).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7941603</ArticleId><ArticleId IdType="pubmed">33687922</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KA, Gubbay J, Hopkins J, Patel S, Buchan SA, et al.. S-gene target failure as a marker of variant B.1.1.7 among SARS-CoV-2 isolates in the greater Toronto area, December 2020 to March 2021. JAMA 325(20):2115–2116 (2021). doi: 10.1001/jama.2021.5607</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5607</ArticleId><ArticleId IdType="pmc">PMC8033504</ArticleId><ArticleId IdType="pubmed">33830171</ArticleId></ArticleIdList></Reference><Reference><Citation>Paton R, Overton C, Ward T. The rapid replacement of the delta variant by omicron (B.1.1.529) in england. Science Translational Medicine 14(652):eabo5395 (2022). doi: 10.1126/scitranslmed.abo5395</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abo5395</ArticleId><ArticleId IdType="pmc">PMC9097877</ArticleId><ArticleId IdType="pubmed">35503007</ArticleId></ArticleIdList></Reference><Reference><Citation>Neath AA, Cavanaugh JE. The bayesian information criterion: background, derivation, and applications. Wiley Interdisciplinary Reviews: Computational Statistics 4(2):199–203 (2012). doi: 10.1002/wics.199</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wics.199</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeling MJ, Dyson L, Guyver-Fletcher G, Holmes A, Semple MG, et al.. Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number. Statistical Methods in Medical Research page 09622802211070257 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9465059</ArticleId><ArticleId IdType="pubmed">35037796</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeling MJ, Dyson L, Tildesley MJ, Hill EM, Moore S. Comparison of the 2021 COVID-19 roadmap projections against public health data in England. Nature communications 13(1):4924 (2022). doi: 10.1038/s41467-022-31991-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31991-0</ArticleId><ArticleId IdType="pmc">PMC9395530</ArticleId><ArticleId IdType="pubmed">35995764</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeling MJ, Moore S, Penman BS, Hill EM. The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England. Nature Communications 14(1):740 (2023). doi: 10.1038/s41467-023-35943-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-35943-0</ArticleId><ArticleId IdType="pmc">PMC9911946</ArticleId><ArticleId IdType="pubmed">36765050</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, et al.. Covid-19 vaccine effectiveness against the omicron (b. 1.1. 529) variant. New England Journal of Medicine 386(16):1532–1546 (2022). doi: 10.1056/NEJMoa2119451</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2119451</ArticleId><ArticleId IdType="pmc">PMC8908811</ArticleId><ArticleId IdType="pubmed">35249272</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Coronavirus (COVID-19) Infection Survey technical article: Cumulative incidence of the percentage of people who have been infected with COVID-19 by variant and age, England: 9 February 2023 (2022a). URL https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsurveytechnicalarticlecumulativeincidenceofthenumberofpeoplewhohavebeeninfectedwithcovid19byvariantandageengland/9february2023. [Online] (Accessed: 2023-02-09).</Citation></Reference><Reference><Citation>Love NK, Ready DR, Turner C, Verlander NQ, French CE, et al.. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial. The Lancet Respiratory Medicine 10(11):1074–1085 (2022). doi: 10.1016/S2213-2600(22)00267-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00267-3</ArticleId><ArticleId IdType="pmc">PMC9625116</ArticleId><ArticleId IdType="pubmed">36228640</ArticleId></ArticleIdList></Reference><Reference><Citation>Prime Miniter’s Office. Prime Minister confirms move to Plan B in England (2021). URL https://www.gov.uk/government/news/prime-minister-confirms-move-to-plan-b-in-england.</Citation></Reference><Reference><Citation>Keeling MJ, Hill EM, Gorsich EE, Penman B, Guyver-Fletcher G, et al.. Predictions of COVID-19 dynamics in the UK: Short-term forecasting and analysis of potential exit strategies. PLOS Comput. Biol. 17(1):e1008619 (2021b). doi: 10.1371/journal.pcbi.1008619</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008619</ArticleId><ArticleId IdType="pmc">PMC7857604</ArticleId><ArticleId IdType="pubmed">33481773</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, et al.. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 584 (7820):257–261 (2020). doi: 10.1038/s41586-020-2405-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2405-7</ArticleId><ArticleId IdType="pubmed">32512579</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ, et al.. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. The Lancet Public Health 5(7):e375–e385 (2020). doi: 10.1016/S2468-2667(20)30133-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30133-X</ArticleId><ArticleId IdType="pmc">PMC7266572</ArticleId><ArticleId IdType="pubmed">32502389</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, et al.. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The lancet infectious diseases 20(5):553–558 (2020). doi: 10.1016/S1473-3099(20)30144-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30144-4</ArticleId><ArticleId IdType="pmc">PMC7158569</ArticleId><ArticleId IdType="pubmed">32171059</ArticleId></ArticleIdList></Reference><Reference><Citation>Birrell P, Blake J, Van Leeuwen E, Gent N, De Angelis D. Real-time nowcasting and forecasting of COVID-19 dynamics in England: the first wave. Philosophical Transactions of the Royal Society B 376 (1829):20200279 (2021). doi: 10.1098/rstb.2020.0279</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2020.0279</ArticleId><ArticleId IdType="pmc">PMC8165585</ArticleId><ArticleId IdType="pubmed">34053254</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin H, Wang Z, Feng S, Sun Z, Yu L, et al.. Transmission dynamics of sars-cov-2 omicron variant infections in hangzhou, zhejiang, china, january-february 2022. International Journal of Infectious Diseases 126:132–135 (2023). doi: 10.1016/j.ijid.2022.10.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.10.033</ArticleId><ArticleId IdType="pmc">PMC9616478</ArticleId><ArticleId IdType="pubmed">36511336</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Wu Y, Kummer AG, Zhao Y, Hu Z, et al.. Assessing changes in incubation period, serial interval, and generation time of sars-cov-2 variants of concern: a systematic review and meta-analysis. BMC medicine 21(1):374 (2023). doi: 10.1186/s12916-023-03070-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03070-8</ArticleId><ArticleId IdType="pmc">PMC10541713</ArticleId><ArticleId IdType="pubmed">37775772</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippiello E, Petrillo G, Baccari S, de Arcangelis L. Estimating generation time of sars-cov-2 variants in italy from the daily incidence rate. Scientific Reports 13(1):11543 (2023). doi: 10.1038/s41598-023-38327-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-38327-y</ArticleId><ArticleId IdType="pmc">PMC10352265</ArticleId><ArticleId IdType="pubmed">37460598</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SW, Sun K, Abbott S, Sender R, Bar-On YM, et al.. Inferring the differences in incubation-period and generation-interval distributions of the delta and omicron variants of sars-cov-2. Proceedings of the National Academy of Sciences 120(22):e2221887120 (2023). doi: 10.1073/pnas.2221887120</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2221887120</ArticleId><ArticleId IdType="pmc">PMC10235974</ArticleId><ArticleId IdType="pubmed">37216529</ArticleId></ArticleIdList></Reference><Reference><Citation>Manica M, De Bellis A, Guzzetta G, Mancuso P, Vicentini M, et al.. Intrinsic generation time of the sars-cov-2 omicron variant: an observational study of household transmission. The Lancet Regional Health–Europe 19 (2022). doi: 10.1016/j.lanepe.2022.100446</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100446</ArticleId><ArticleId IdType="pmc">PMC9246701</ArticleId><ArticleId IdType="pubmed">35791373</ArticleId></ArticleIdList></Reference><Reference><Citation>UKHSA. COVID-19 vaccine surveillance report: Week 51 (2021). URL https://assets.publishing.service.gov.uk/media/61c462f2e90e07196a66be6d/Vaccine_surveillance_report_-_week_51.pdf.</Citation></Reference><Reference><Citation>Office for National Statistics. Coronavirus and the social impacts on Great Britain: 1 April 2022 (2022b). URL https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/bulletins/coronavirusandthesocialimpactsongreatbritain/1april2022. [Online] (Accessed: 2024-06-27).</Citation></Reference><Reference><Citation>Jarvis C, Gimma A, Wong K, Edmunds J. Descriptive analysis of social contacts in the UK during Christmas period in 2020 and 2021 from the CoMix social contact survey Report comparing contacts over Christmas (2022). URL https://cmmid.github.io/topics/covid19/reports/comix/Comix%20Report%20Christmas.pdf.</Citation></Reference><Reference><Citation>Verelst F, Willem L, Beutels P. Behavioural change models for infectious disease transmission: a systematic review (2010–2015). Journal of The Royal Society Interface 13(125):20160820 (2016). doi: 10.1098/rsif.2016.0820</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2016.0820</ArticleId><ArticleId IdType="pmc">PMC5221530</ArticleId><ArticleId IdType="pubmed">28003528</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk S, Bansal S, Bauch CT, Eames KT, Edmunds WJ, et al.. Nine challenges in incorporating the dynamics of behaviour in infectious diseases models. Epidemics 10:21–25 (2015). doi: 10.1016/j.epidem.2014.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2014.09.005</ArticleId><ArticleId IdType="pubmed">25843377</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams L, Rasmussen S, Kleczkowski A, Maharaj S, Cairns N. Protection motivation theory and social distancing behaviour in response to a simulated infectious disease epidemic. Psychology, health &amp; medicine 20(7):832–837 (2015). doi: 10.1080/13548506.2015.1028946</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13548506.2015.1028946</ArticleId><ArticleId IdType="pubmed">25835044</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaller M, Murray DR, Hofer MK. The behavioural immune system and pandemic psychology: the evolved psychology of disease-avoidance and its implications for attitudes, behaviour, and public health during epidemic outbreaks. European Review of Social Psychology 33(2):360–396 (2022). doi: 10.1080/10463283.2021.1988404</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10463283.2021.1988404</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore S, Hill EM, Tildesley MJ, Dyson L, Keeling MJ. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect. Dis. 21(6):793–802 (2021). doi: 10.1016/S1473-3099(21)00143-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00143-2</ArticleId><ArticleId IdType="pmc">PMC7972312</ArticleId><ArticleId IdType="pubmed">33743847</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeling MJ, Moore SJ. An assessment of the vaccination of school-aged children in England. BMC Med 20:196 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9113775</ArticleId><ArticleId IdType="pubmed">35581585</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford University Press; (1992).</Citation></Reference><Reference><Citation>Griffin J, Casey M, Collins Á, Hunt K, McEvoy D, et al.. Rapid review of available evidence on the serial interval and generation time of COVID-19. BMJ Open 10(11):e040263 (2020). doi: 10.1136/bmjopen-2020-040263</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040263</ArticleId><ArticleId IdType="pmc">PMC7684810</ArticleId><ArticleId IdType="pubmed">33234640</ArticleId></ArticleIdList></Reference><Reference><Citation>Challen R, Dyson L, Overton CE, Guzman-Rincon LM, Hill EM, et al.. Early epidemiological signatures of novel SARS-CoV-2 variants: establishment of B. 1.617. 2 in England. medRxiv (2021b).</Citation></Reference><Reference><Citation>Keeling MJ. Patterns of reported infection and reinfection of sars-cov-2 in england. Journal of Theoretical Biology 556:111299 (2023). doi: 10.1016/j.jtbi.2022.111299</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2022.111299</ArticleId><ArticleId IdType="pmc">PMC9568275</ArticleId><ArticleId IdType="pubmed">36252843</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem K, Cook AR, Jit M. Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLOS Comput. Biol. 13(9):e1005697 (2017). doi: 10.1371/journal.pcbi.1005697</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1005697</ArticleId><ArticleId IdType="pmc">PMC5609774</ArticleId><ArticleId IdType="pubmed">28898249</ArticleId></ArticleIdList></Reference><Reference><Citation>Google. COVID-19 Community Mobility Reports (2020). URL https://www.google.com/covid19/mobility/. [Online] (Accessed: 15 May 2022).</Citation></Reference><Reference><Citation>Gimma A, Munday J, Wong K, Coletti P, van Zandvoort K, et al.. Changes in social contacts in england during the covid-19 pandemic between march 2020 and march 2021 as measured by the comix survey: A repeated cross-sectional study. PLoS Medicine page 1003907 (2022). doi: 10.1371/journal.pmed.1003907</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003907</ArticleId><ArticleId IdType="pmc">PMC8887739</ArticleId><ArticleId IdType="pubmed">35231023</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperial College London. The REACT 2 programme (2020). URL https://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/the-react-2-programme/. [Online] (Accessed: 25 July 2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>